Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Considerations for the design and conduct of pediatric obesity pharmacotherapy clinical trials: Proceedings of expert roundtable meetings.
Kelly AS, Bahlke M, Baker JL, de Beaufort C, Belin RM, Fonseca H, Hale PM, Holm JC, Hsia DS, Jastreboff AM, Juliusson PB, Murphy M, Pak J, Paul E, Rudolph B, Srivastava G, Tornøe CW, Weghuber D, Fox CK. Kelly AS, et al. Among authors: jastreboff am. Pediatr Obes. 2024 Nov;19(11):e13161. doi: 10.1111/ijpo.13161. Epub 2024 Sep 17. Pediatr Obes. 2024. PMID: 39289849 Review.
Tirzepatide Once Weekly for the Treatment of Obesity.
Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A; SURMOUNT-1 Investigators. Jastreboff AM, et al. N Engl J Med. 2022 Jul 21;387(3):205-216. doi: 10.1056/NEJMoa2206038. Epub 2022 Jun 4. N Engl J Med. 2022. PMID: 35658024 Clinical Trial.
Tirzepatide for Obesity Treatment and Diabetes Prevention.
Jastreboff AM, le Roux CW, Stefanski A, Aronne LJ, Halpern B, Wharton S, Wilding JPH, Perreault L, Zhang S, Battula R, Bunck MC, Ahmad NN, Jouravskaya I; SURMOUNT-1 Investigators. Jastreboff AM, et al. N Engl J Med. 2024 Nov 13. doi: 10.1056/NEJMoa2410819. Online ahead of print. N Engl J Med. 2024. PMID: 39536238
Survodutide for treatment of obesity: rationale and design of two randomized phase 3 clinical trials (SYNCHRONIZE™-1 and -2).
Wharton S, le Roux CW, Kosiborod MN, Platz E, Brueckmann M, Jastreboff AM, Ajaz Hussain S, Pedersen SD, Borowska L, Unseld A, Kloer IM, Kaplan LM; SYNCHRONIZE‐1 and ‐2 trial committees and investigators. Wharton S, et al. Among authors: jastreboff am. Obesity (Silver Spring). 2024 Nov 4. doi: 10.1002/oby.24184. Online ahead of print. Obesity (Silver Spring). 2024. PMID: 39495965
GLP-1 programs the neurovascular landscape.
Chen B, Yu X, Horvath-Diano C, Ortuño MJ, Tschöp MH, Jastreboff AM, Schneeberger M. Chen B, et al. Among authors: jastreboff am. Cell Metab. 2024 Oct 1;36(10):2173-2189. doi: 10.1016/j.cmet.2024.09.003. Cell Metab. 2024. PMID: 39357509 Review.
Ending Weight Stigma to Advance Health Equity.
Pearl RL, Donze LF, Rosas LG, Agurs-Collins T, Baskin ML, Breland JY, Byker Shanks C, Cooksey Stowers K, Johnson S, Lee BY, Martin MY, Mujuru P, Odoms-Young A, Panza E, Pronk NP, Calicutt K, Nadglowski J, Nece PM, Tedder M, Chow LS, Krishnamurti H, Jay M, Xi D, Jastreboff AM, Stanford FC. Pearl RL, et al. Among authors: jastreboff am. Am J Prev Med. 2024 Nov;67(5):785-791. doi: 10.1016/j.amepre.2024.06.021. Epub 2024 Jun 28. Am J Prev Med. 2024. PMID: 38945180 No abstract available.
Effect of Semaglutide on Regression and Progression of Glycemia in People With Overweight or Obesity but Without Diabetes in the SELECT Trial.
Kahn SE, Deanfield JE, Jeppesen OK, Emerson SS, Boesgaard TW, Colhoun HM, Kushner RF, Lingvay I, Burguera B, Gajos G, Horn DB, Hramiak IM, Jastreboff AM, Kokkinos A, Maeng M, Matos ALSA, Tinahones FJ, Lincoff AM, Ryan DH; SELECT Trial Investigators. Kahn SE, et al. Among authors: jastreboff am. Diabetes Care. 2024 Aug 1;47(8):1350-1359. doi: 10.2337/dc24-0491. Diabetes Care. 2024. PMID: 38907683 Free PMC article. Clinical Trial.
62 results